| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Invesque Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.099 |
| 52 Week High | CA$0.21 |
| 52 Week Low | CA$0.089 |
| Beta | 1.11 |
| 11 Month Change | -37.61% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -43.57% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| 7ZL | DE Real Estate | DE Market | |
|---|---|---|---|
| 7D | -21.6% | 1.9% | 0.8% |
| 1Y | n/a | 11.9% | 2.0% |
Return vs Industry: Insufficient data to determine how 7ZL performed against the German Real Estate industry.
Return vs Market: Insufficient data to determine how 7ZL performed against the German Market.
Price Volatility
| 7ZL volatility | |
|---|---|
| 7ZL Average Weekly Movement | 19.3% |
| Real Estate Industry Average Movement | 4.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 7ZL's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 7ZL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 1,766 | Adlai Chester | invesque.com |
Invesque Inc. operates as a health care real estate company in North America. The company's investment property portfolio includes investments in independent living, assisted living, memory care, skilled nursing, and transitional care properties. It also includes investments in owner occupied seniors housing properties, including the ownership of real estate properties, as well as provides management services.
Invesque Inc. Fundamentals Summary
| 7ZL fundamental statistics | |
|---|---|
| Market cap | €5.75m |
| Earnings (TTM) | -€79.28m |
| Revenue (TTM) | €175.92m |
0.0x
P/S Ratio-0.1x
P/E RatioIs 7ZL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7ZL income statement (TTM) | |
|---|---|
| Revenue | US$188.45m |
| Cost of Revenue | US$123.92m |
| Gross Profit | US$64.53m |
| Other Expenses | US$149.46m |
| Earnings | -US$84.93m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.51 |
| Gross Margin | 34.24% |
| Net Profit Margin | -45.07% |
| Debt/Equity Ratio | 419.1% |
How did 7ZL perform over the long term?
See historical performance and comparison